Short term neoadjuvant androgen deprivation therapy does not affect prostate specific membrane antigen expression in prostate tissues
Sam S. Chang(Memorial Sloan Kettering Cancer Center), Paul B. Gaudin(Unknown), Lana S. Grauer(Beckman Coulter Foundation), Brian Hutchinson(Joint Global Change Research Institute), W. D. W. Heston(Memorial Sloan Kettering Cancer Center), Victor E. Reuter(Memorial Sloan Kettering Cancer Center)
Cited by 34
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Aberrant Nuclear Immunoreactivity for TFE3 in Neoplasms With TFE3 Gene Fusions
|The American Journal of Surgical Pathology|2003|611
PRCC-TFE3 Renal Carcinomas
|The American Journal of Surgical Pathology|2002|362
Selection of tumor antigens as targets for immune attack using immunohistochemistry: II. Blood group-related antigens
|International Journal of Cancer|1997|294
Standardization of Radical Cystectomy and Pelvic Lymph Node Dissection for Bladder Cancer: A Collaborative Group Report
|The Journal of Urology|2004|293